In 2013, Cascio S. et al. reported for the first time the interaction between the tumor form of MUC1 and CIN85 [12] and showed that this association promotes the invasiveness of cancer cells and metastasis formation thus rendering it a viable target for pharmacological intervention in cancer therapy [12]. The gene discussed is SH3KBP1; the disease is neoplasm.